This company listing is no longer active
Learning 2 Sleep L2S Resultados de beneficios anteriores
Pasado controles de criterios 0/6
Learning 2 Sleep L2S's earnings have been declining at an average annual rate of -42.6%, while the Healthcare industry saw earnings growing at 6.5% annually. Revenues have been growing at an average rate of 7.7% per year.
Información clave
-42.6%
Tasa de crecimiento de los beneficios
n/a
Tasa de crecimiento del BPA
| Crecimiento de la industria Healthcare | 15.7% |
| Tasa de crecimiento de los ingresos | 7.7% |
| Rentabilidad financiera | -129.2% |
| Margen neto | -292.4% |
| Última actualización de beneficios | 30 Jun 2022 |
Actualizaciones de resultados anteriores recientes
No hay actualizaciones
Recent updates
No hay actualizaciones
Desglose de ingresos y gastos
Cómo gana y gasta dinero Learning 2 Sleep L2S. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 30 Jun 22 | 7 | -20 | 0 | 0 |
| 31 Mar 22 | 7 | -18 | 0 | 0 |
| 31 Dec 21 | 7 | -16 | 0 | 0 |
| 31 Dec 20 | 5 | -5 | 0 | 0 |
| 31 Dec 19 | 1 | -5 | 0 | 0 |
| 31 Dec 18 | 0 | -4 | 0 | 0 |
Ingresos de calidad: HT60 is currently unprofitable.
Margen de beneficios creciente: HT60 is currently unprofitable.
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: HT60 is unprofitable, and losses have increased over the past 5 years at a rate of 42.6% per year.
Acelerando crecimiento: Unable to compare HT60's earnings growth over the past year to its 5-year average as it is currently unprofitable
Beneficios vs. Industria: HT60 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-23.9%).
Rentabilidad financiera
Alta ROE: HT60 has a negative Return on Equity (-129.21%), as it is currently unprofitable.